News | June 04, 2008

GE Provides Chinese Olympic Athletes ECGs for Cardiac Diagnosis

June 5, 2008 - GE Healthcare will provide electrocardiogram technologies (ECG) to the Chinese Olympic Committee (COC) for diagnosing cardiac fitness of competing Chinese athletes to help ensure they achieve optimum performance during the Beijing 2008 Olympic Games.

GE Healthcare will deliver its MAC 5500 resting ECG, one Dash 4000 bed-side monitor and one CASE STRESS ECG (including the T2100 treadmill). GE Healthcare’s ECG products are designed to help physicians in emerging markets, whether they work in a hospital setting or in a private practice, to better predict and diagnose patients at risk of heart disease.

Located at the Beijing Sports Medicine Hospital, GE Healthcare’s electrocardiogram technologies will be used by clinicians for routine athlete medical examinations of China’s National teams. Early diagnosis of an athlete’s cardiac function allows clinicians to develop more adaptive training programs for each athlete and in turn prepare them in the best possible way for reaching gold medal.

GE Healthcare’s MAC 5500 resting ECG comes with a suite of arrhythmia detection and ECG cardiovascular analysis and interpretation programs that allow clinicians to address a wider range of cardiac disease management needs.

GE Healthcare’s CASE Stress system, also provided to the COC, is an exercise testing system that combines hardware and software to acquire, manage and store stress-testing data. During the stress test, the athlete is put on a treadmill and must go through a rigorous exercise protocol while their ECG information is acquired. Capturing an ECG during exercise provides physicians with valuable information regarding cardiac performance and heart rate recovery times.

The lightweight and wireless DASH 4000 Patient Monitor will provide the COC with the adaptability to handle virtually any monitoring situation. Clinicians can use this flexible device to monitor physiologic parameter data in assessing the well being of the athletes' cardiovascular performance during their rigorous training period for the Olympic Games.

For more information: www.ge.com/olympicgames


Related Content

Feature | ECG | Samir Awasthi, MD, PhD

For decades, medicine has treated the electrocardiogram as a familiar, inexpensive and indispensable test, but also as ...

Home June 16, 2026
Home
News | ECG

June 2, 2026 —HeartSciences Inc. has announced the commercial release of MyoVista Insights version 1.3, a major platform ...

Home June 05, 2026
Home
News | ECG

June 2, 2026 — AccurKardia, Inc. has been granted US Patent No. 12,620,488 for the company's proprietary machine ...

Home June 02, 2026
Home
News | ECG

May 7, 2026 — AccurKardia, a provider of ECG-based diagnostics technology, recently announced that AK+ Guard has been ...

Home May 08, 2026
Home
News | ECG

April 15, 2026 – AliveCor has received CE Mark (Conformité Européenne) for the Kardia 12L electrocardiogram (ECG) System ...

Home April 15, 2026
Home
News | ECG

March 4, 2026 — HeartBeam, Inc. has announced a commercial partnership with ClearCardio. In addition to serving as ...

Home March 06, 2026
Home
News | ECG

March 3, 2026 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...

Home March 04, 2026
Home
News | ECG

Feb. 10, 2026 – AccurKardia, a provider of ECG-based diagnostics technology, recently announced results from a new study ...

Home February 24, 2026
Home
News | ECG

Feb. 18, 2026 — Researchers at the Mount Sinai Kravis Children’s Heart Center led a multicenter effort to develop and ...

Home February 20, 2026
Home
News | ECG

Dec. 10, 2025 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to HeartBeam, Inc. for its 12 ...

Home February 16, 2026
Home
Subscribe Now